PPBT250117P5000
- 1.15
- 0.000.00%
Purple Biotech Newsroom
Purple Biotech Shares Resume Trade
Purple Biotech Shares Halted On Circuit Breaker To The Downside, Stock Now Down -29.2%
Purple Biotech Secures $2.8 Million for Oncology Advancements
Purple Biotech Shares Are Trading Lower After the Company Announced a $2.8 Million Offering of 472,688 ADS.
Purple Biotech Signs Securities Purchase Agreement
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
Why Purple Biotech (PPBT) Stock Is Getting Hammered
Purple Biotech Announces $2.8M Offering Of 472,668 ADS.
ADRs Advance; Purple Biotech Ltd. Climbs 150%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Trending Stocks Today | Senti Biosciences Surges 445.37%
December 2nd - US stocks trending in regular trading hours.Gainers: $Senti Biosciences(SNTI.US)$ soars 445.37% to $11.78 with a turnover of $1.13 billion. $Purple Biotech(PPBT.US)$ surges 189.12% to $
Purple Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.9%
Economic Data in Focus as US Equity Futures Waver Pre-Bell
Purple Biotech Shares Jump on Positive Phase 2 Cancer Drug Study Results
Top Premarket Gainers
Purple Biotech Reported Final Results From Phase 2 Study Of Its Lead Oncology Drug, CM24, In Patients With Pancreatic Ductal Adenocarcinoma
HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target
Purple Biotech's Promising Trials and Financial Update
Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M